Printer Friendly

Browse Health care industry topic

Product development subtopic

Articles

1-150 out of 150 article(s)
Title Author Type Date Words
Medipharm Labs initiates trial for use of cannabis in Chronic Kidney Disease. Oct 19, 2020 196
Luminex receives USD5.39m from BARDA to support FDA 510(k) Filing for NxTAG RPP including SARS-CoV-2 and most up-to-date respiratory pathogen targets. Sep 25, 2020 248
Luminex receives USD5.39m from BARDA to support FDA 510(k) Filing for NxTAG RPP including SARS-CoV-2 and most up-to-date respiratory pathogen targets. Sep 25, 2020 252
Trials for phase III of coronavirus vaccine starts in Abu Dhabi. Arab News Jul 25, 2020 184
The path to serology testing at Beaumont Health. Wilson, Linda Jun 1, 2020 967
Roche Reports Positive Results From Third-Phase Archway Study. May 27, 2020 194
Tissue Regenix develops new product line in collaboration with global healthcare giant. May 12, 2020 360
Antibe Therapeutics expects results from Phase 2B study of pain drug ATB-346 within six weeks. May 5, 2020 355
NetScientific Investee PDS Biotechnology To Develop Covid-19 Vaccine. Apr 17, 2020 203
MediWound temporarily suspends enrollment in EscharEx phase 2 study. Mar 30, 2020 379
Journal Gastroenterology Publishes Ironwood Pharmaceuticals IW-3718 Phase IIb Data. Mar 3, 2020 424
Philippines races to develop drug against dengue. Gilbert P. Felongco, Correspondent Dec 22, 2019 459
eWellness Healthcare developing new rheumatoid arthritis treatment platform RA360. Nov 13, 2019 350
Clinical Trials Market Growing Strong By 2023 / Global Industry Size, Share, Trends, Technology Development, Regional Overview, Demand Overview & Statista. Oct 29, 2019 933
Clinical Trials Market Global Value by Estimated Size, Valuable Shares, Current Scenario, Future Predictions, Comprehensive Study by Key Players Till 2023. Report Oct 23, 2019 909
Clinical Trials Market 2019 Global Market Size, Share, Trends, Share, Competitive Analysis, Growth, Revenue, And Regional Forecast & Foreseen by 2023. Sep 26, 2019 914
Janssen Reports Top-Line Phase 3 Results for Tremfya in Adults with Active Psoriatic Arthritis. Financial report Jun 19, 2019 473
ViiV Healthcare submits NDA for two-drug regimen of cabotegravir, rilpivirine. Apr 29, 2019 211
New Phase 3 STELARA Data Show Positive Results as Maintenance Therapy in Adults with Moderate to Severe Ulcerative Colitis. Mar 12, 2019 241
New Phase 3 Data Demonstrate Superiority of Tremfya vs Cosentyx in Delivering PASI 90 Responses in the Treatment of Moderate to Severe Plaque Psoriasis at Week 48. Clinical report Dec 17, 2018 139
H. Lundbeck and Otsuka report positive clinical phase II data for the combination treatment of brexpiprazole and sertraline for treatment of PTSD. Disease/Disorder overview Dec 3, 2018 426
H. Lundbeck and Otsuka report positive clinical phase II data for the combination treatment of brexpiprazole and sertraline for treatment of PTSD. Disease/Disorder overview Dec 3, 2018 422
Astaxanthin Shown to Benefit Seniors with Sarcopenia. Dec 1, 2018 377
Transfusions. Oct 1, 2018 268
Janssen updates results of international Phase 3 clinical study of esketamine nasal spray in patients with treatment resistant depression. Clinical report Sep 24, 2018 328
Janssen updates results of international Phase 3 clinical study of esketamine nasal spray in patients with treatment resistant depression. Clinical report Sep 24, 2018 324
ProAxsis assays selected for 1,000-patient respiratory trial. Sep 20, 2018 163
ProAxsis assays selected for 1,000-patient respiratory trial. Sep 20, 2018 159
Lancaster lab fast-tracking innovative healthcare technologies. Fields, Hannah Aug 16, 2018 861
Phase 3 Renal Outcomes Trial of Invokana Stopped Early Based on Positive Efficacy. Jul 23, 2018 320
Medtronic starts enrollment in trial for ECG Belt for heart failure therapy. Jul 19, 2018 258
Trial Data Indicate Durability of Response of Kymriah in Adults with Relapsed or Refractory DLBCL. Jun 22, 2018 285
PS33m to develop new healthcare products; IN BRIEF. Jun 13, 2018 161
PS33m to develop new healthcare products; IN BRIEF. Jun 13, 2018 155
Metastatic Urothelial Cancer Drug Erdafitinib Yields Positive Results in Phase 2 Study. Clinical report Jun 8, 2018 271
Bayer submits Larotrectinib's NDA under US FDA priority review for cancers harbouring NTRK gene fusion. May 30, 2018 241
Bayer submits Larotrectinib's NDA under US FDA priority review for cancers harbouring NTRK gene fusion. May 30, 2018 237
monARC Bionetworks commences strategic Integration with Roivant drug development platform. May 7, 2018 245
monARC Bionetworks commences strategic Integration with Roivant drug development platform. May 7, 2018 241
BerGenBio Enrolls 22 NSCLC Patients in First Stage of Phase II Trial of Bemcentinib Combined with Keytruda. Apr 16, 2018 320
BerGenBio Enrolls 22 NSCLC Patients in First Stage of Phase II Trial of Bemcentinib Combined with Keytruda. Apr 12, 2018 320
Abbott and Surmodics announce agreement for SurVeil drug-coated balloon. Feb 27, 2018 122
Novo Nordisk announces completion of the first phase 3a trial, PIONEER 1, with oral semaglutide. Feb 23, 2018 365
Novo Nordisk announces completion of the first phase 3a trial, PIONEER 1, with oral semaglutide. Feb 23, 2018 366
Novo Nordisk announces completion of the first phase 3a trial, PIONEER 1, with oral semaglutide. Feb 23, 2018 361
TherapeuticsMD Submits NDA for TX-001HR to US FDA. Dec 29, 2017 216
FDA Accepts TherapeuticsMD NDA Resubmission for TX-004HR. Dec 20, 2017 311
Lundbeck and Otsuka announce initiation of a third phase III trial for brexpiprazole for treatment of agitation in dementia patients. Nov 2, 2017 240
Lundbeck and Otsuka announce initiation of a third phase III trial for brexpiprazole for treatment of agitation in dementia patients. Nov 2, 2017 236
RightAnswer.com wins USD999,922 Phase II CDC Small Business Innovation Grant. Oct 17, 2017 211
Merck Presents 22.5 Month Follow-up Data from Phase 3 Trial of Keytruda (pembrolizumab) in Advanced Urothelial Carcinoma at ESMO 2017 Congress. Sep 12, 2017 543
Mithra publishes results from Estelle Phase IIb FIESTA study. Jun 26, 2017 249
Mithra publishes results from Estelle Phase IIb FIESTA study. Jun 26, 2017 245
Health network: from design to manufacturing services, NH firms; play key roles in medical device production. Rajala, Liisa Sep 30, 2016 1059
Roche starts enrolling patients for phase III trials of Lampalizumab. Aug 15, 2016 146
Roche starts enrolling patients for phase III trials of Lampalizumab. Aug 15, 2016 142
TherapeuticsMD submits NDA for vaginal softgel capsule Yuvvexy. Jul 8, 2016 156
TherapeuticsMD submits NDA for vaginal softgel capsule Yuvvexy. Jul 8, 2016 152
Atossa Genetics commences oral endoxifen new drug development programme. Jun 9, 2016 128
Merck's sBLA for KEYTRUDA accepted for review by the US FDA for recurrent or metastatic head and neck squamous cell carcinoma. Apr 14, 2016 306
Merck's sBLA for KEYTRUDA accepted for review by the US FDA for recurrent or metastatic head and neck squamous cell carcinoma. Apr 14, 2016 302
The Medicines Company passes US FDA's Fast Track Designation for CARBAVANCE (meropenem-vaborbactam) for complicated urinary tract infections. Apr 12, 2016 229
The Medicines Company passes US FDA's Fast Track Designation for CARBAVANCE (meropenem-vaborbactam) for complicated urinary tract infections. Apr 12, 2016 233
NantBioScience signs cooperative research and development agreement with the National Cancer Institute. Apr 7, 2016 204
NantBioScience signs cooperative research and development agreement with the National Cancer Institute. Apr 7, 2016 200
Regeneron and Sanofi's BLA for sarilumab accepted for review by the US FDA. Jan 8, 2016 239
Regeneron and Sanofi's BLA for sarilumab accepted for review by the US FDA. Jan 8, 2016 235
Eli Lilly plans to withdraw phase III trial of evacetrapib. Oct 14, 2015 156
Eli Lilly plans to withdraw phase III trial of evacetrapib. Oct 14, 2015 160
Laboratory Corporation of America Holdings secures multi-year agreement for use of Xcellerate platform in worldwide clinical trials portfolio. Aug 25, 2015 230
Laboratory Corporation of America Holdings secures multi-year agreement for use of Xcellerate platform in worldwide clinical trials portfolio. Aug 25, 2015 232
AETHLON MEDICAL SIGNS CLINICAL TRIAL AGREEMENT. May 1, 2015 326
AETHLON ENTERS CANCER CLINICAL TRIAL AGREEMENT. May 1, 2015 327
ForaCare, RollTech develop FORA connected health watch. Brief article Apr 16, 2015 197
ForaCare, RollTech develop FORA connected health watch. Brief article Apr 16, 2015 208
Regeneron Pharmaceuticals and Bayer HealthCare reveal positive results from Phase III VIVID-DME trial of EYLEA injection. Jul 22, 2014 139
Regeneron Pharmaceuticals and Bayer HealthCare reveal positive results from Phase III VIVID-DME trial of EYLEA injection. Jul 22, 2014 135
InSite Vision to submit DexaSite's NDA to US FDA for blepharitis in adults in 2015. Jul 9, 2014 240
InSite Vision to submit DexaSite's NDA to US FDA for blepharitis in adults in 2015. Jul 9, 2014 236
Bayer HealthCare starts patient enrollment in COAST trial evaluating regorafenib tablets. Feb 24, 2014 137
Bayer HealthCare starts patient enrollment in COAST trial evaluating regorafenib tablets. Feb 24, 2014 133
Bayer HealthCare and Regeneron report positive two-year results from Phase III VISTA-DME trial of VEGF Trap-Eye. Feb 12, 2014 148
Bayer HealthCare and Regeneron report positive two-year results from Phase III VISTA-DME trial of VEGF Trap-Eye. Feb 12, 2014 144
InSite Vision to begin Phase 3 clinical study of BromSite for reduction of inflammation and pain after cataract surgery. Report Oct 2, 2013 189
InSite Vision to begin Phase 3 clinical study of BromSite for reduction of inflammation and pain after cataract surgery. Report Oct 2, 2013 175
GlaxoSmithKlinea[euro]s DERMA trial fails to meet primary endpoint. Sep 10, 2013 139
GlaxoSmithKlinea[euro]s DERMA trial fails to meet primary endpoint. Sep 10, 2013 135
CryoLife Inc wins FDA's conditional IDE approval to commence clinical trials for PerClot in the US. Jun 20, 2013 246
CryoLife Inc wins FDA's conditional IDE approval to commence clinical trials for PerClot in the US. Jun 20, 2013 242
LabCorp Clinical Trials to provide global central laboratory services to Bristol-Myers Squibb Company. Apr 1, 2013 146
InSite Vision Incorporated concludes Phase 3 clinical study of BromSite in patients with pain associated after cataract surgery. Clinical report Jan 11, 2013 231
InSite Vision Incorporated concludes Phase 3 clinical study of BromSite in patients with pain associated after cataract surgery. Clinical report Jan 11, 2013 217
InSite Vision Incorporated commences dosing of BromSite in Phase 3 clinical study to reduce pain associated with cataract surgery. Clinical report Nov 30, 2012 195
InSite Vision Incorporated commences dosing of BromSite in Phase 3 clinical study to reduce pain associated with cataract surgery. Clinical report Nov 30, 2012 191
SIMUL8 Corporation to Develop Landmark Lean Healthcare Product. Sep 30, 2012 353
InSite Vision Incorporated conducts the DOUBle Phase 3 trial of AzaSite Plus & DexaSite for chronic eye disease, blepharitis. Sep 10, 2012 188
InSite Vision Incorporated conducts the DOUBle Phase 3 trial of AzaSite Plus & DexaSite for chronic eye disease, blepharitis. Sep 10, 2012 184
Bayer HealthCare submits NDA to FDA for regorafenib for GIST; Initiates expanded access programme for GIST patients. Aug 31, 2012 213
Bayer HealthCare submits NDA to FDA for regorafenib for GIST; Initiates expanded access programme for GIST patients. Aug 31, 2012 209
-Siemens Magnetom System gets FDA clearance. Jul 24, 2012 501
BRICS pledge healthcare support for Africa: just as the world's economic centre of gravity is shifting North to South and West to East, and as traditional donors deal with a financial crisis that is impacting their aid assistance to Africa, the BRICS nations are developing a new focus on global health issues. Stephen Williams reports. Williams, Stephen May 1, 2012 1599
Onyx Pharmaceuticals' ASPIRE trial to support full approval of carfilzomib in patients with relapsed multiple myeloma following target enrollment. Feb 23, 2012 214
Pharmos doses first patients in levotofisopam clinical trial. Jan 11, 2012 205
CryoLife intiates enrollment in US clinical trial for its BioFoam protein hydrogel technology. Warren, Jim Nov 1, 2011 231
ViiV Healthcare begins Phase III HIV study of Celsentri/Selzentry versus Truvada, in combination with protease inhibitor. Oct 12, 2011 192
Morphosys, Bayer Healthcare cancer antibody programme advances into Phase I. Sep 14, 2011 139
Bayer, Onyx start enrollment in Phase III trial of Nexavar combined with capecitabine in advanced breast cancer. Feb 24, 2011 241
Shionogi-ViiV Healthcare initiates Phase III trial for '572-Trii' fixed-dose combination HIV therapy. Feb 3, 2011 241
InSite Vision Inc enrolls 160 patients in ISV-303 Phase 1/2 clinical trial for post-surgical ocular pain and swelling. Jan 6, 2011 173
Breakthrough Regenerative Therapy for Newborns with Metabolic Disorders in Qatar. Oct 12, 2010 704
Assess patient needs, secure payment. Brief article Sep 1, 2010 128
InSite Vision Inc begins Phase 1/2 clinical trial of ISV-303 for post-surgical ocular pain and swelling. Aug 24, 2010 165
InSite Vision starts Phase I/II study of ISV-303 for post-surgical ocular pain, swelling. Aug 23, 2010 265
FDA roundup: VisionCare Inc. Jul 12, 2010 500
GE Healthcare reports interim Phase II study data for PET agent. Jun 10, 2010 239
GE HEALTHCARE GETS POSITIVE FLUTEMETAMOL PHASE 2 DATA. Apr 27, 2010 476
Bayer, Onyx report Phase II study data for Nexavar plus chemotherapy in advanced breast cancer. Dec 14, 2009 713
Onyx Pharmaceuticals Inc (Emeryville CA) and Germany's Bayer AG said their Nexavar pill, approved for liver and kidney tumors, extended the lives of women with advanced breast cancer by delaying growth of malignancies that had spread or recurred. Brief article Dec 14, 2009 238
Onyx Pharmaceuticals Inc. Brief article Oct 5, 2009 194
Women with breast cancer lived significantly longer without their disease getting worse when treated with Germany's Bayer AG and Onyx Pharmaceuticals Inc's (Emeryville CA) cancer pill Nexavar, researchers said. Brief article Sep 28, 2009 249
LR-based health drink poised to remain secret no longer. Carter, Mark Jun 1, 2009 769
U.S. HHS allocates $1B for new flu vaccine. Brief article May 22, 2009 274
Provenge shows survival benefit in prostate cancer. Birk, Susan Report May 15, 2009 640
Dendreon Corp. Brief article Apr 20, 2009 115
Laboratory Corp of America. Brief article Oct 13, 2008 147
FDA denial of anticancer drug spurs lawsuit. Burke, Cathy Brief article Nov 1, 2007 144
MEDICINES : HEADING TOWARDS CHANGES IN THE CLINICAL TRIAL DIRECTIVE. Oct 8, 2007 788
Investing in new medical technologies: a decision framework. Cosh, Emma; Girling, Alan; Lilford, Richard; McAteer, Helen; Young, Terry Aug 1, 2007 4794
Clinical. Brief article Jul 31, 2007 151
Immune-boosting prostate cancer vaccine endorsed by FDA advisors. McBride, Deborah Jul 1, 2007 613
Barr Laboratories Inc. (Woodcliff Lake NJ) won approval for a generic version of Nimotop, which prevents brain damage resulting from aneurysm or hemorrhage. Brief article May 7, 2007 199
Novartis AG won approval for the hypertension medicine Tekturna--a potential blockbuster that has shown the ability to lower blood pressure more effectively than common treatments. Mar 12, 2007 158
Guided breathing lowers blood pressure in type 2 diabetes. Tucker, Miriam E. Clinical report Feb 1, 2007 547
Mobile decision support. Brief article Mar 1, 2006 131
Progress on a work in progress: CHRISTUS Health tackles workflow management and transcription challenges in a massive initiative designed for enterprise consistency. Blair, Robin Editorial Jan 1, 2006 1893
Propranolol, other drugs eyed to block PTSD: idea is that blocking [beta]-adrenergic receptors might tone down consolidation of emotional memories. Kilgore, Christine Jan 1, 2005 1653
CryoLife receives FDA, CE Mark approval to distribute new delivery system for BioGlue. Brief Article May 30, 2004 151
Atrix licenses prostate cancer products in Korea. Brief Article Feb 1, 2004 249
Special pacemaker may shrink heart enlarged by CHF. Brief Article Aug 11, 2003 297
Laser scans find a perfect prosthetic fit. (Computing). Thilmany, Jean Brief Article Jul 1, 2003 139
Quality improvement: getting to how. Clancy, Carolyn Apr 1, 2003 1671
Wireless Healthcare expects 3G to promote spread of e-health. Brief Article Feb 13, 2003 128
Medical mortgage. (Real Deals). Waldon, George Brief Article Nov 11, 2002 106
BioE and Loma Linda to develop Alzheimer's Disease diagnostic tests. Brief Article Jul 1, 2001 288
Project Management. O'Neill, John Jun 1, 2001 601
Computational Bioimaging for Medical Diagnosis and Treatment. JOHNSON, CHRISTOPHER R. Mar 1, 2001 752
ARTIFICIAL HIP DESIGN MIMICS NATURE. DEGASPARI, JOHN Brief Article Jan 1, 2000 863
ATTRACTING CONSUMERS--MAGNET VENDORS SEEK STAYING POWER. Eckhouse, Kim Feb 22, 1999 598
Bill Gates eyes the healthcare market. Dunbar, Carolyn Feb 1, 1995 1559
Health management technology goes one on one with Bill Gates. Dunbar, Carolyn Interview Feb 1, 1995 1853

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters